biotech
CSL Limited Enters Flu Vaccine Market
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on February 7, 2006
BlogPicture

CSL Limited, An Australian pharmaceutical company, is planning to enter the flu vaccine market in 2007. The company is planning to file for regualtory approval early next year, in time for the flu season in fall 2007 and spring 2008.

CSL is confident that there is room for them in the marketplace, considering that the other big pharma companies such as Sanofi pasteur, GlaxoSmithKline and Chiron are revving up their productions. MedImmune even had a nasal spray version of the flu vaccine developed.
McNamee [CSL's chief executive said] said CSL provides geographical and seasonal diversity as a supplier - Australia's flu season peaks in July and August, compared with January and February for the U.S. - which gives the company leverage when another manufacturer experiences production problems.

CSL also is testing a prototype for a bird flu vaccine that could be ready within two years.


The public can just benefit from more companies producing flu vaccines (or any other product for that matter), right?

Read full story from SeattlePI.com.

Permalink: CSL Limited Enters Flu Vaccine Market
Tags: flu  vaccine  biotech  market  enters  enters+vaccine  vaccine+market  limited+enters 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/15114
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for CSL Limited Enters Flu Vaccine Market:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 4 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!